Keyword: Centers for Disease Control and Prevention
The egg-based production process might have made this season's flu shot only 10% effective.
Pharma stands to prevail again in Washington, D.C., if a new Part D rule proposal from the Centers for Medicare & Medicaid Services makes its way into law.
The CDC committee in charge of vaccination policy in the U.S. endorsed GlaxoSmithKline's Shingrix over the older shot, Merck's Zostavax.
Marking a big step in its march toward potential approval, GlaxoSmithKline’s shingles vaccine candidate Shingrix won the support of an FDA panel.
Efforts to boost the national HPV vaccination rate are yielding some positive results, new data from the CDC show.
A global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues.
New Hampshire filed a lawsuit against Purdue Pharma for allegedly leading an information campaign to boost opioid perception among prescribers.
For three of the world’s top four vaccine companies, sales growth churned along in the second quarter as other areas struggled.
It's summer, when few are thinking about the coming influenza threat. But top vaccine makers are already kicking off their flu shot shipments.
After fears that President Trump may push for a change in vaccine policy, Fitzgerald's appointment will likely be a relief to medical professionals.